The 2024 EUHA Expo, held grandly in Hannover, Germany, attracted more than 130 exhibitors and around 9,000 professionals from 90 countries worldwide. Rehear Audiology Company Ltd., in collaboration with Realtek Semiconductor, showcased its industry-leading AI hearing solutions, becoming a highlight of the event. During the expo, over 50 headphone and hearing aid companies from Denmark, Germany, the United States, Asia, and more engaged in in-depth collaboration talks with Rehear Audiology, demonstrating the market's strong demand for its AI hearing technologies.
Introducing Innovative AI Technology with a Focus on the “EASIER & CLEARER” Concept
Globally, 1.5 billion people are affected by hearing loss, most of whom experience mild to moderate impairments. However, due to the high cost and complicated fitting processes of traditional hearing aids, only 10% of those with mild to moderate hearing loss choose to use them. Rehear Audiology aims to redefine hearing care with AI technology, making high-quality auditory experiences easily accessible to more people.
EASIER: AI-Powered Simplification of Hearing Tests and Fitting
Rehear Audiology’s innovative technology simplifies the traditional hearing aid fitting process. With AI-powered active noise cancellation (ANC) for soundproof-free hearing tests and RehearFit real-ear verification technology, users can complete a professional hearing test and personalized compensation in just 15 minutes via a mobile app and headphones, offering a convenient and comfortable experience.
CLEARER: AI Adaptive Noise Reduction Technology
The intelligent noise reduction and Clear audio technology can reduce background noise by up to 40dB in noisy environments, isolating human voices and creating a quiet listening environment. It provides saturated sound capture of 625K and high-quality, full-range audio with a frequency of 22.5KHz. The technology compensates for sound loss with up to 441 channels, processing received audio at a speed of 0.2 milliseconds. This eliminates the occlusion effect, allowing users to enjoy a clear and natural auditory experience.
Collaborative Innovation and Market Expansion
At the EUHA expo, Rehear Audiology engaged in deep discussions with several industry-leading companies. Rehear Audiology provides an E2E solution from R&D to market deployment, with its products clinically validated by Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, solidifying its market leadership.
Looking Ahead
With the U.S. FDA’s approval of the OTC hearing aid regulations in 2022, the global hearing care market is expected to reach $1.5 trillion by 2030. Rehear Audiology will continue to drive innovation in AI hearing technology and expand into international markets. Its successful debut in Germany has laid a solid foundation for its entry into the European market, and the company will continue to expand into other major markets, enabling more people worldwide to enjoy the “EASIER & CLEARER” hearing experience.
